ATP5F1A and Dystonia: Elsewhere, we have identified a group of three unrelated patients harboring variants in ATP5F1A, which codes for the α‐subunit of ATPase, and also have begun to show that the associated clinical outcomes are heterogeneous, ranging from transient neurodevelopmental impairment to chronic movement disorder syndromes with dystonia and spasticity.7